These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1561532)

  • 21. WEB 2086. A potent PAF antagonist exerts protective effect toward PAF-induced gastric damage.
    Brambilla A; Ghiorzi A; Giachetti A
    Pharmacol Res Commun; 1987 Feb; 19(2):147-51. PubMed ID: 3588650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the mechanism of endothelin-induced rat gastric mucosal lesion formation].
    Katoh N; Itoh M; Yokoyama Y; Joh T
    Nihon Shokakibyo Gakkai Zasshi; 1994 Jan; 91(1):27-35. PubMed ID: 8309086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat.
    Yamada T; Tomioka K; Horie M; Sakurai Y; Nagaoka H; Mase T
    Biochem Biophys Res Commun; 1991 Apr; 176(2):781-5. PubMed ID: 2025290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A study on changes and its mechanisms of intestinal mucosal permeability after severe burn].
    Yu P; Xiao G; Fu W
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1996 Sep; 12(5):372-5. PubMed ID: 9387456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet activating factor as a proinflammatory mediator in acetic-induced colitis in the rat.
    Will PC; Thomas TK; Iverson L; Buckman D; Weis W; Wilson C; Srivastava A
    Agents Actions; 1991 Sep; 34(1-2):181-4. PubMed ID: 1793026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The roles of platelet activating factor in intestinal mucosal barrier injury after burn].
    Yu P; Xiao G; Fu W
    Zhonghua Wai Ke Za Zhi; 1995 Jul; 33(7):393-5. PubMed ID: 8565724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rat liver blood flow after ischemia and reperfusion. The effects of the platelet-activating factor antagonist WEB-2170 and of removing circulating leukocytes.
    Chávez-Cartaya RE; Metcalfe S; Ramirez-Romero P; Calne R; Jamieson NV
    Transplantation; 1994 May; 57(10):1440-4. PubMed ID: 8197604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential antagonism of platelet activating factor-induced neutrophilia and gastric hemorrhage in the rat.
    Thomas TK; Chesonis RS; Schmolze D; Symington J; Harbison ML; Walser A; Will PC
    Agents Actions; 1993; 39 Spec No():C195-7. PubMed ID: 8273566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-activating factor mediates pulmonary macromolecular leak following intestinal ischemia-reperfusion.
    Carter MB; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 1996 Feb; 60(2):403-8. PubMed ID: 8598677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of burn-induced gastric mucosal injury by an endothelin receptor antagonist in rats.
    Battal NM; Hata Y; Ito O; Matsuda H; Yoshida Y; Kawazoe T; Nagao M
    Burns; 1997 Jun; 23(4):295-9. PubMed ID: 9248637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelin-induced sudden death and the possible involvement of platelet activating factor (PAF).
    Terashita Z; Shibouta Y; Imura Y; Iwasaki K; Nishikawa K
    Life Sci; 1989; 45(20):1911-8. PubMed ID: 2689821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia.
    Stahl GL; Terashita Z; Lefer AM
    J Pharmacol Exp Ther; 1988 Mar; 244(3):898-904. PubMed ID: 3252036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
    Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
    J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309.
    Takatani M; Maezaki N; Imura Y; Terashita Z; Nishikawa K; Tsushima S
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():943-6. PubMed ID: 1825438
    [No Abstract]   [Full Text] [Related]  

  • 35. Involvement of superoxide anion and platelet-activating factor in increased tissue-type plasminogen activator during rat gastric microvascular damages.
    Kurose I; Suematsu M; Miura S; Suzuki M; Nagata H; Morishita T; Sekizuka E; Tsuchiya M
    Thromb Res; 1991 May; 62(4):241-8. PubMed ID: 1650966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of platelet-activating factor-induced gastrointestinal lesions in rats by the new specific antagonist N-(2-dimethylaminoethyl)-N-(3-pyridinylmethyl)[4-(2,4,6-triisopropylphe nyl) thiazol-2yl]amine.
    Giudice A; Herbert JM; Maffrand JP; Manara L; Manzoni L; Le Fur G
    Arzneimittelforschung; 1996 Apr; 46(4):407-12. PubMed ID: 8740089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating factor stimulates gastric acid secretion in isolated rabbit gastric glands.
    Sobhani I; Bado A; Moizo L; Laigneau JP; Tarrade T; Braquet P; Lewin MJ
    Am J Physiol; 1995 Jun; 268(6 Pt 1):G889-94. PubMed ID: 7611410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD; Mikulaschek AW
    Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of platelet-activating factor antagonists on early bacteria translocation of rat after burn injury].
    Qin X; Yu P; Yuan J
    Zhonghua Wai Ke Za Zhi; 1995 Apr; 33(4):217-8. PubMed ID: 7587673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-activating factor and the vascular effects of zymosan in rats.
    Damas J; Remacle-Volon G; Bourdon V
    Eur J Pharmacol; 1993 Feb; 231(2):231-6. PubMed ID: 8453979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.